World hemophilia day 2025








.


New logo, same celebration!


We are thrilled to unveil the brand-new logo for World Hemophilia Day! The new design is modern and confident, and reflects the optimism surrounding the important discussions happening in the bleeding disorders community today.



On April 17, 2025, the global bleeding disorders community will come together to celebrate World Hemophilia Day. This year’s theme is “Access for all: Women and girls bleed too”.






.

Today, women and girls with bleeding disorders (WGBDs) are still underdiagnosed and underserved. The global bleeding disorders community has the power—and the responsibility—to change this. Through recognition, diagnosis, treatment, and care, the quality of life of women and girls will improve, and the bleeding disorders community will become stronger.

.


CAMPAIGN MATERIALS





World Hemophilia Day 2025 —Celebrating Strength, Awareness, and Life-Saving Plasma Donations


April 17, 2025, marks the 36th year of celebrating
World Hemophilia Day
—a global movement to raise awareness about hemophilia and honor the strength of those living with this rare bleeding disorder. At Octapharma Plasma, this day is an opportunity to recognize the vital role of our amazing donors and dedicated staff.


What Is Hemophilia?


Hemophilia is a genetic bleeding disorder where blood doesn’t clot properly due to the lack of clotting proteins known as clotting factors. This can lead to prolonged bleeding after an injury, surgeries, or even spontaneous bleeding into joints or muscles. Living with hemophilia often requires ongoing treatments, vigilant care, and access to life-saving therapies. 


How Plasma Donations Help Hemophilia Patients


Plasma, the straw-colored liquid component of your blood, is full of valuable proteins critical for clotting and immunity. Plasma treatments are essential for people with hemophilia. They rely on
plasma-derived therapies
or
recombinant products
to replenish their missing clotting factors. This drastically improves their quality



World Hemophilia Day 17 April 2025 | Theme & Importance






World Hemophilia Day is a global healthcare event celebrated on the 17th of April every year
, started by the World Federation of Haemophilia (WHF) with the intention to raise a call for the government authorities and local policymakers for the provision of a better treatment and care in addition to promote better control and prevention with haemophilia.

A rare severe, inherited haemorrhagic disorder, haemophilia is caused by malfunction of factor VIII and factor IX protein (factors required for blood clotting/ coagulation), leading to an abnormality in blood coagulation. Although people of all races and ethnicities can be diagnosed with haemophilia, men are more likely to be affected because the ailment is connected to the X chromosome. There is a 50% probability that a boy whose mother carries the haemophilia gene will also be affected by haemophilia, and her daughter being 50% risk of being carrier. Hence, haemophilia is more common in males, despite the fact that it can affect females, causing difficulties with menstruation and childbirth.



World Hemophilia Day 2025 Theme




This year, 2025, World Hemophi

Today is World Hemophilia Day!


17/04/2025

Today, April 17, 2025, we celebrate World Hemophilia Day. This year's theme is "Access for All: Women and Girls Bleed Too." Worldwide, women and girls with bleeding disorders are still underdiagnosed and inadequately supported.

A few years ago, it was common practice to automatically diagnose women with low Factor VIII or Factor IX levels as 'carriers,' even if these levels were ≤ 0.4 IU/ml. In 2024, HemoNED made the important decision to reclassify carriers of hemophilia with low factor levels (factor levels ≤ 0.4 IU/ml) to mild hemophilia. By the end of 2023, the register included 157 women with hemophilia carrier status and 35 women diagnosed with hemophilia.

In the 2024 annual report, which will be released next month, the reality will be better mapped out. We hope to achieve better care for women with hemophilia through targeted treatment and support, including greater understanding of their situation.